UK Anticoagulants Market (2020-2026) – Size Expected to reach Highest CAGR of 9.8% | Bayer AG, Pfizer, Inc., Sanofi S.A.
Pune, Maharashtra, India, January 13 2021 (Wiredrelease) Brandessence Market Research and Consulting Pvt ltd –:Global Anticoagulants Market is valued at USD 20.12 Billion in 2018 and expected to reach USD 35.26 Billion by 2024 with the CAGR of 9.8% over the forecast period.
The growing incidences of cardiovascular disorders, chronic diseases, and venous thromboembolism (VTE) are the major factor which driving the growth of global anticoagulants market.
Scope of the Global Anticoagulants Market Report-
Anticoagulants are medicines that help prevent blood clots. They’re given to people at a high risk of getting clots, to reduce their chances of developing serious conditions like strokes and heart attacks. A blood clot is a seal created by the blood to prevent bleeding from wounds. If a blood clot blocks the flow of blood through a vessel, the affected a part of the body will become starved of oxygen and can stop working properly. Examples of Anticoagulants include aspirin, heparin and warfarin. 5.7% of those using aspirin and warfarin experienced major bleeding events after one year, compared to 3% of these on warfarin only. Anticoagulants are used to treat and stop blood clots which will occur in blood vessels. Blood clots can block blood vessels.
Get Sample of This Report@ https://brandessenceresearch.com/requestSample/PostId/1045
Global Anticoagulants market report is segmented on the basis of drug class, route of administration, application and regional & country level. Based upon drug class Anticoagulants market is classified into NOACs, Eliquis, Bevyxxa, Xarelto, Savaysa & lixiana, Pradaxa, Heparin & LMWH, Vitamin K antagonist and others. Based upon route of administration Anticoagulants market is classified into Oral anticoagulant, Injectable anticoagulant. Based upon Application Anticoagulants market is classified into atrial fibrillation & heart attack, Stroke, Deep vein thrombosis (DVT), pulmonary embolism (PE) and others.
The regions covered in this Global Anticoagulants market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level market of Home Healthcare is sub divided into U.S., Mexico, Canada, UK, France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.
Global Anticoagulants market Report covers prominent players are like,
Aspen Holdings Bayer AG Boehringer Ingelheim GmbH Bristol-Myers Squibb Company Daiichi Sankyo Company Limited GlaxoSmithKline plc. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Pfizer, Inc. Portola Pharmaceuticals, Inc. Sanofi S.A. Other
The growing incidences of cardiovascular disorders, chronic diseases, and venous thromboembolism (VTE) and increasing acceptance of novel oral anticoagulants (NOACs), are the major driving factors which driving the growth of global anticoagulants market.
Growing incidences of cardiovascular disorders, chronic diseases, and venous Thromboembolism (VTE) are expected to drive the growth of anticoagulants market. Patients with recognized cardiovascular disease may suffer further cardiovascular procedures, despite receiving optimal medical treatment. Although platelet inhibition plays a central role in the prevention of new procedures, use of anticoagulant therapies to reduce cardiovascular disorders disease. According to American Heart association cardiovascular disease is the leading global cause of death, accounting for more than 17.6 million deaths per year. A number that is expected to grow to more than 23.6 million by 2030.The precise number of people affected by venous thromboembolism is unknown, although as many as 900,000 people could be affected each year in the United States. Oral anticoagulants are widely used for long-term prevention and treatment of venous and arterial thromboembolism. However, stringent regulations set by various governments hamper the growth of the global anticoagulants market. Increasing in development of oral anticoagulants, formulations containing pharmaceutical ingredient with help of new oral anticoagulants technology can provide great opportunities for growth in oral anticoagulants market.
North America is dominating the Anticoagulants Market
North America is expected to dominate the growth of global anticoagulants market due to increasing incidences of cardiovascular disorders, chronic diseases, and venous thromboembolism. Chronic diseases such as heart disease, cancer, and diabetes are the leading causes of death and disability in the United States. Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United State. 1,806,590 new cancer cases and 606,520 cancer deaths are projected to occur in the United States In 2020. Venous thromboembolism (VTE) occurs for the first time in 100 persons out of 100,000 each year in the United States. Asia Pacific is anticipated to grow at the fastest growth rate due to increasing geriatric population. According to the China national group, in 2017, the proportion of Chinese citizens above 60 years old obtained 17.3 percent, approximately above 241 million.
Global Anticoagulants Market Segmentation –
By drug class:- NOACs, Eliquis, Bevyxxa, Xarelto, Savaysa & lixiana, Pradaxa, Heparin & LMWH, Vitamin K antagonist, Others
By route of administration:- Oral anticoagulant, Injectable anticoagulant
By application:- Atrial fibrillation & heart attack, Stroke, Deep vein thrombosis (DVT), Pulmonary embolism (PE), Others
Full Research Report @ https://brandessenceresearch.com/pharmaceutical/global-anticoagulants-market-size
About us: Brandessence Market Research and Consulting Pvt. Ltd.
Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals, and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations, and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.
Contact us at: +44-2038074155 or mail us at firstname.lastname@example.org
This content has been published by Brandessence Market Research and Consulting Pvt ltd company. The WiredRelease News Department was not involved in the creation of this content. For press release service enquiry, please reach us at email@example.com.